New agents in ovarian cancer
- 1 August 1982
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 8 (8) , 1431-1434
- https://doi.org/10.1016/0360-3016(82)90595-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- High-dose platinum for the treatment of refractory ovarian cancerGynecologic Oncology, 1981
- IN-VITRO CLONOGENIC ASSAY FOR PREDICTING RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPYThe Lancet, 1980
- PHASE-II TRIAL OF HEXAMETHYLMELAMINE IN OVARIAN-CARCINOMA RESISTANT TO ALKYLATING-AGENTS1979
- Hexamethylmelamine in alkylating agent-resistant ovarian carcinomaCancer, 1978
- Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agentsGynecologic Oncology, 1978
- DIRECT CLONING OF HUMAN OVARIAN CARCINOMA CELLS IN AGAR1978
- Phase II Evaluation of Cytembena (NSC-104801) in Patients With Advanced Ovarian Carcinoma Resistant to Alkylating Agents: Brief Communication 2JNCI Journal of the National Cancer Institute, 1977
- Dose response evaluation of adriamycin in human neoplasiaCancer, 1977
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977
- PHASE-2 STUDY OF CIS-DICHLORODIAMMINEPLATINUM(II) (NSC-119875) IN ADVANCED ADENOCARCINOMA OF OVARY1976